Medtronic competes in the medical device market against Johnson & Johnson and is receiving institutional backing from major financial firms including BlackRock, Vanguard, and State Street.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Medtronic competes in the medical device market against Johnson & Johnson and is receiving institutional backing from major financial firms including BlackRock, Vanguard, and State Street.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Medtronic plc
medical device company
Related events
- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.
- Medtronic expands its Hugo system via investment and Jim Cramer views the company as a quandary stock.
- Medtronic plc is a global healthcare technology company headquartered in Galway, Ireland, with executives including Thierry Piéton and Greg Smith.
- Medtronic acquired Given Imaging, and the FDA published an early alert regarding a product recall.
Coverage
Newest first; wire copies grouped- Insider MonkeyMedtronic plc (MDT): A Bull Case Theory We came across a bullish thesis on Medtronic plc on Max Dividends’s Substack. In this article, we will summarize the bulls’ thesis on MDT. Medtronic plc's shar